How Can Pharma Companies Save up to $45M in Early Drug Development?
How Can Pharma Companies Save up to $45M in Early Drug Development?
Patheon’s Jennifer Therrien discusses findings of a Tufts Center for the Study of Drug Development (CSDD) study that reveals how pharmaceutical companies using a single-source outsourcing partner can achieve a net gain of $45 million in early drug development.

Added Date:

2022-05-20

Filters:

Filter Category Filter Values
Specialty
  • Clinical supply demand planning, sourcing and optimization
  • Early development
Language
  • English
Asset Type
  • Video
Country
  • All
Region
  • Global
Content Category
  • Collateral

Country Availability:


()

Gated Form:

None Set